Idiopathic Pulmonary Fibrosis Treatment Market size was valued at USD 4.28 billion in 2025 and is estimated to reach USD 4.57 billion in 2026, before advancing to USD 7.81 billion by 2034, registering a compound annual growth rate (CAGR) of 6.90% between 2026 and 2034. Growth is being driven by the rising global prevalence of idiopathic pulmonary fibrosis (IPF), an aging population more...